scispace - formally typeset
I

Iris E. Jansen

Researcher at VU University Amsterdam

Publications -  72
Citations -  8966

Iris E. Jansen is an academic researcher from VU University Amsterdam. The author has contributed to research in topics: Disease & Medicine. The author has an hindex of 23, co-authored 54 publications receiving 5907 citations. Previous affiliations of Iris E. Jansen include German Center for Neurodegenerative Diseases & VU University Medical Center.

Papers
More filters
Journal ArticleDOI

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

Alan E. Renton, +85 more
- 20 Oct 2011 - 
TL;DR: The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) locus contains one of the last major unidentified autosomal-dominant genes underlying these common neurodegenerative diseases, and a large hexanucleotide repeat expansion in the first intron of C9ORF72 is shown.
Journal ArticleDOI

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

Iris E. Jansen, +65 more
- 01 Mar 2019 - 
TL;DR: A large genome-wide association study of clinically diagnosed AD and AD-by-proxy identifies new loci and functional pathways that contribute to AD risk and adds novel insights into the neurobiology of AD.
Journal ArticleDOI

The genetic architecture of the human cerebral cortex

Katrina L. Grasby, +359 more
- 20 Mar 2020 - 
TL;DR: Results support the radial unit hypothesis that different developmental mechanisms promote surface area expansion and increases in thickness and find evidence that brain structure is a key phenotype along the causal pathway that leads from genetic variation to differences in general cognitive function.
Journal ArticleDOI

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Céline Bellenguez, +401 more
- 01 Apr 2022 - 
TL;DR: This paper performed a two-stage genome-wide association study with 111,326 clinically diagnosed/proxy AD cases and 677,663 controls and found 75 risk loci, of which 42 were new at the time of analysis.